Krystal Biotech Stock Analysis

Krystal Stock Analysis Notes

About 12.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania. Krystal Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 119 people. To find out more about Krystal Biotech contact the company at 412 586 5830 or learn more at https://www.krystalbio.com.

Krystal Biotech Investment Alerts

Krystal Biotech Upcoming and Recent Events

Krystal Largest EPS Surprises

View All Earnings Estimates

Krystal Biotech Environmental, Social, and Governance (ESG) Scores

Krystal Stock Institutional Investors

Note, although Krystal Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Krystal Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.39 B.

Krystal Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.45 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.45.

Management Efficiency

Krystal Biotech has return on total asset (ROA) of 0.0688 % which means that it generated a profit of $0.0688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1034 %, meaning that it created $0.1034 on every $100 dollars invested by stockholders. Krystal Biotech's management efficiency ratios could be used to measure how well Krystal Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.09 in 2025. Return On Capital Employed is likely to gain to 0.07 in 2025. At this time, Krystal Biotech's Asset Turnover is comparatively stable compared to the past year.

Technical Drivers

As of the 23rd of March, Krystal Biotech secures the Mean Deviation of 1.99, downside deviation of 2.51, and Risk Adjusted Performance of 0.0844. Krystal Biotech technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Krystal Biotech standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Krystal Biotech is priced some-what accurately, providing market reflects its recent price of 187.15 per share. Given that Krystal Biotech has jensen alpha of 0.2609, we recommend you to check Krystal Biotech's last-minute market performance to make sure the company can sustain itself at a future point.

Krystal Biotech Price Movement Analysis

Krystal Biotech Insider Trading Activities

Krystal Biotech Outstanding Bonds

Krystal Biotech Predictive Daily Indicators

Krystal Biotech Corporate Filings

Krystal Biotech Forecast Models

Krystal Biotech's time-series forecasting models are one of many Krystal Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Krystal Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Krystal Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Krystal shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Krystal Biotech. By using and applying Krystal Stock analysis, traders can create a robust methodology for identifying Krystal entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Krystal analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Krystal analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Krystal Biotech stock analysis indicators help investors evaluate how Krystal Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Krystal Biotech shares will generate the highest return on investment. By understating and applying Krystal Biotech stock analysis, traders can identify Krystal Biotech position entry and exit signals to maximize returns.

When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.